HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases
Gabriela Paroni, Marco Bolis, Adriana Zanetti, Paolo Ubezio, Kristian Helin, Peter Staller, Lars Ole Gerlach, Maddalena Fratelli, Richard M. Neve, Mineko Terao, Enrico Garattini*
Dive into the research topics of 'HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases'. Together they form a unique fingerprint.